Speakers
Chris Gagliardi
Principal
Sanofi Venture
David Gold
Vice President Business Development
Sonoma Biotherapeutics
David Pajerowski
Founding Chief Technology Officer
Flip Therapeutics
Donmienne Leung
Director AbbVie Ventures
AbbVie
Emma Smith
Head of Immune Reset
UCB
Frank Brennan
Head of Immunology Translation
UCB
Jonathan Zombeck
Director Business Development
Visterra, an Otsuka Company
Jordan Zwick
Chief Business Officer
Mirador Therapeutics
Julia Manasson
Medical Director
Seismic Therapeutic
Julie Di Paolo
Senior Director, Immunology Scientific Innovation Lead
Johnson & Johnson
Julien Genovino
Associate Director, Global Business Development & Strategy
Otsuka
Kalpana Gupta
Head of Immunology, Infectious Diseases & Metabolism Partnering
Regeneron
Kevin White
Head of Immune Tolerance Therapeutics Discovery
AbbVie
Luke Henry
Chief Business Officer
Quell Therapeutics
Max Zeiberg
Vice President Business Development
Sana Biotechnology
Melissa Matzelle
Director, Immunology Search & Evaluation
AbbVie
Neel Desai
Executive Director, Business Development
Biogen
Nicola La Monica
Senior Director, Strategic Search & Evaluation
Johnson & Johnson
Paul Andrews
Director, External Innovation
Biogen
Saifur Rahman
Director, Business Development & Licensing
Sanofi
Samik Basu
Chief Scientific Officer
Cabaletta
Sean Evans
Senior Associate Venture Investments
Johnson & Johnson
Swarna Balasubramanian
Associate Director, Search & Evaluation, Respiratory & Immunology
AstraZeneca
Tatiana Ort
Head of Bioscience Immunology
AstraZeneca
Albert Hsia
Executive Director, Business Development
Merck
Brian Freed
Chief Scientific Officer
Rhuemagen